Form 483

TAMPASTA LIMITED LIABILITY COMPANY Form 483, 2026-06-26

FDA issued a Form 483 to TAMPASTA LIMITED LIABILITY COMPANY on 2026-06-26 with 3 public-safe observations.

483· Form 483 issuedFoods & Cosmetics3 observations

TAMPASTA LIMITED LIABILITY COMPANY · Clearwater, United States · Issued June 26, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Jun 2026
21 CFR 117.130(a)(1)

Hazard analysis - Conducted

Cited by Megan K Otero, Andrew J Mcguffin

26 Jun 2026
21 CFR 117.4

Qualifications of individuals

Cited by Megan K Otero, Andrew J Mcguffin

26 Jun 2026
21 CFR 117.405(a)(1)

Supply-chain program - Establish

Cited by Megan K Otero, Andrew J Mcguffin

Inspected site

TLTAMPASTA LIMITED LIABILITY COMPANYClearwater, United States

Inspection team

AJAndrew J Mcguffin

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 117.130(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 117.4Cited across public-safe Form 483 observations1x
21 CFR 117.405(a)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere